MedTrace Logo

Mobile Health Program for Post-Preeclampsia Hypertension

NCT07599579 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-05-20

No results posted yet for this study

Summary

Strategies targeted to optimize hypertension (HTN) control for midlife women after hypertensive disorders of pregnancy (HDP) have not been studied, despite evidence of a critical need. This proposal targets the 10-20 years postpartum as a key time when women have subclinical cardiovascular (CV) sequelae of uncontrolled HTN and are primed for CV prevention interventions. Before proceeding with large-scale intervention trials of a home blood pressure monitoring (HBPM) and coaching intervention following HDP, further pilot testing is necessary. The overarching hypothesis of this proposal is that a new monitoring and treatment paradigm utilizing HBPM combined with a virtual coaching intervention would be better than standard of care for mid-life women with prior HDP who develop HTN. Women will be assigned in an unblinded manner to the intervention or standard of care control group.

Conditions

  • Hypertension (HTN)
  • Preeclampsia
  • Hypertensive Disorders of Pregnancy (HDP)

Interventions

BEHAVIORAL

Coaching application

A digital application for providing education and support for home-based blood pressure monitoring.

BEHAVIORAL

Home-based blood pressure monitoring

Device for measuring blood pressure at home with blue tooth connectivity for automated collection.

OTHER

WebMD

Smartphone-based application for health education and/or monitoring.

Sponsors & Collaborators

  • McKamish Family Foundation

    collaborator UNKNOWN

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Malamo Countouris, MD, MS · University of Pittsburgh

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-14
Primary Completion
2027-07-31
Completion
2027-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07599579 on ClinicalTrials.gov